June 18, 2004
For Immediate Release
Spine Surgery Technologies and Products Improving Less Invasiveness and Quality of Outcomes, Yet Many Market Opportunities Remain, According to New MedMarket Diligence Report
FOOTHILL RANCH, CA— A diverse array of diseases and disorders of the spine have been the target of spine surgery procedures and technologies that have achieved significant clinical success as well as success in medtech markets. The clinical practices and technology development continue to evolve and develop to improve outcomes cost. Spine conditions include congenital disorders, inflammatory and infectious diseases, degenerative diseases, traumatic conditions and mechanical disorders. The MedMarket Diligence report details the current and future market worldwide for spine surgery technologies, providing a wealth of information on disease incidence, clinical practices and technology and market development.
The MedMarket Diligence report,
http://www.mediligence.com/rpt-m501.htm, details a market and technology
assessment and forecast of the products and technologies in the management of
diseases and disorders of the spine. The report describes the specific diseases
and disorders of the spine, characterizing the patient populations, their
current clinical management, and trends in clinical management as new techniques
and technologies are expected to be developed and emerge. The report details the
currently available products and technologies, and the manufacturers offering
them. The report details the products and technologies under development and
markets for each in spine surgery. The report provides a current and forecast
assessment of the U.S., Western Europe and Pacific Rim markets for these
technologies, with particular emphasis on the market impact of new technologies
through the coming decade, and will profile a minimum of 40 key companies in
this industry detailing their current products, current market position and
products under development.
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the “MedMarkets” newsletter, a monthly analysis of the market implications of new medical technology and dedicated reports on technology markets. For more information on MedMarket Diligence, LLC, contact Patrick Driscoll at (949) 859-3401, e-mail, or visit http://www.mediligence.com.